Doug Locke is an organizational leader and the CEO of SSI Strategy, where he brings more than three decades of experience building high-performing teams, designing enterprise-level strategies, and driving transformation across the life sciences sector.  He focuses on delivering primary and supplemental delivery teams to achieve POC, IND-enabling, FIH and other longer ranging market-facing outcomes. Doug is focused on leveraging the SSI teaming model to achieve market outcomes for client partners of the firm. 

With a career spanning consulting, governance, and venture advisory roles, he specializes in developing market-facing partnerships and supporting medical and scientific leaders through key inflection points. Doug is committed to leaving every organization better than he found it and excels at navigating complex issues involving governance, funding, and growth. He is known for his collaborative leadership style and passion for helping others succeed.  

Kim Kushner, MPH, is the Chief Business Officer at SSI Strategy, where she drives business growth and builds trusted partnerships with biotech and pharmaceutical leaders. With over 15 years of experience in healthcare and life sciences consulting, Kim specializes in helping executive teams design, scale, and transform organizations to bring innovative therapies to patients faster. At SSI, she oversees growth strategy, marketing, sales, and account management across the portfolio. Kim also serves as a Lecturer at Yale University and as Chair of the American Cancer Society’s Greater New York City Area Board. She is recognized for her ability to blend strategic insight with hands-on collaboration, guiding companies through critical inflection points from development to commercialization.